Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trial.

Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trial. Respir Res. 2011 Sep 28; 12:129.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.